Trial Scorecards
Trial Scorecards
June 06, 2019
1 min read
Save

EXTEND

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers assessed whether administering IV tissue plasminogen activator between 3 and 9 hours after the onset of stroke improved outcomes compared with placebo.